- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | The observation status for Magle Chemoswed Holding AB is updated | 154 | GlobeNewswire | On June 9, 2026, the shares in Magle Chemoswed Holding AB (the "Company") were given observation status with reference to uncertainty in respect of the issuer's financial position.
Today, July... ► Artikel lesen | |
| Mo | Magle Chemoswed Holding AB: The board of Magle Chemoswed Holding AB (publ) proposes that the EGM resolves on voluntary delisting of the company's shares from Nasdaq First North Growth Market | 187 | GlobeNewswire (Europe) | The board of directors of Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), has today resolved to propose that an extraordinary general meeting resolves on the delisting of the... ► Artikel lesen | |
| 10.07. | Magle Chemoswed Holding AB: Magle Group Has Resolved On A Restructuring Of Its Outstanding Debt And Capital Structure, Including Debt-for-equity Swap, Issuance Of Super Senior Bonds And Directed Share Issues | 260 | GlobeNewswire (Europe) | As previously announced, Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") has for some time been in constructive negotiations with bondholders representing approximately 79 per cent... ► Artikel lesen | |
| 30.06. | Magle Chemoswed Holding AB: Bulletin from the Annual General Meeting in Magle Chemoswed Holding AB (publ) | 179 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 30 June 2026, held its Annual General Meeting at the Company's premises at Agneslundsvägen 20B in Malmö. The following... ► Artikel lesen | |
| 25.06. | Magle Chemoswed Holding AB: Magle Group announces deferral of interest payment in respect of its bonds, and update to timing of intended financial restructuring | 196 | GlobeNewswire (Europe) | As communicated by Magle Chemoswed Holding AB (publ) ("Magle Group" or the "Company") on 11 June 2026, the Company received a proposal from an ad hoc group of bondholders (the "Ad Hoc Group") in respect... ► Artikel lesen | |
| 09.06. | Magle Chemoswed Holding AB receives observation status | 170 | GlobeNewswire | On June 7, 2026, Magle Chemoswed Holding AB (the "Company") disclosed a press release with an update regarding the Company's financing arrangements.
According to item 6.1.3 (b) (iv) of the Nasdaq... ► Artikel lesen | |
| 07.06. | Magle Chemoswed Holding AB: Magle Chemoswed Holding AB - Update on Financing Arrangements and Ongoing Stakeholder Discussions | 166 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ) ("Magle" or the "Company") provides an update regarding its financing arrangements and ongoing discussions with key stakeholders.
Danske Bank Facility Maturing on 30... ► Artikel lesen | |
| 31.05. | Magle Chemoswed Holding AB: Magle Chemoswed Holding Reports Financial Results For First Quarter 2026 | 151 | GlobeNewswire (Europe) | A difficult quarter in a year of necessary change
Q1 2026 KEY INDICATORSTotal revenue amounted to 71.7 MSEK (85.1)EBITDA equalled -6.6 MSEK (12.8)Operating profit (EBIT) was -17.8 MSEK (2.1)Profit after... ► Artikel lesen | |
| MAGLE CHEMOSWED Aktie jetzt für 0€ handeln | |||||
| 26.05. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 273 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 26 May 2026, held an Extraordinary General Meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B in... ► Artikel lesen | |
| 12.05. | New last trading day for paid subscription shares (BTA) of Magle Chemoswed Holding AB | 246 | GlobeNewswire | At the request of Magle Chemoswed Holding AB, the last trading day in Magle Chemoswed Holding AB's paid subscription shares will be changed from 2026-05-20 to 2026-05-13.
Instrument:
Paid subscription... ► Artikel lesen | |
| 30.04. | Magle Chemoswed Holding AB: Magle Group Announces Outcome of Rights Issue | 244 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 14.04. | Magle Chemoswed Holding AB: Magle Group Publishes Information Document in Connection with Upcoming Rights Issue | 268 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 13.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 13.04.2026 | 203 | Xetra Newsboard | Das Instrument LUR SE0015192075 LUXBRIGHT AB EQUITY wird ex Kapitalmassnahme gehandelt am 13.04.2026 The instrument LUR SE0015192075 LUXBRIGHT AB EQUITY is traded ex capital adjustment on 13.04.2026Das... ► Artikel lesen | |
| 10.04. | Magle Chemoswed Holding AB: Bulletin from the extraordinary general meeting in Magle Chemoswed Holding AB (publ) | 200 | GlobeNewswire (Europe) | Magle Chemoswed Holding AB (publ), reg. no. 556913-4710 (the "Company"), today, on 10 April 2026, held an Extraordinary General Meeting (the "EGM") at the Company's premises at Agneslundsvägen 20B in... ► Artikel lesen | |
| 27.03. | Magle Chemoswed Holding AB: Magle Chemoswed Holding Reports Financial Results For Fourth Quarter 2025 | 229 | GlobeNewswire (Europe) | Magle Group's Q4 report highlights restructuring measures, portfolio clean-up and a focus on improving profitability in a challenging financial environment.
Q4 2025 KEY INDICATORSNet Sales amounted... ► Artikel lesen | |
| 25.03. | Magle Chemoswed Holding AB: Magle Group's Board Of Directors Has Resolved On A Rights Issue Of Approx Sek 40 Million And Agreed A Revised Financing Package | 244 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 18.02. | Magle Chemoswed Holding AB: Magle Group Issues Profit Warning Ahead of Q4 and Full-Year 2025 Results | 214 | GlobeNewswire (Europe) | Magle Group today issues a profit warning in advance of the publication of its Q4 2025 Interim Report and Full-Year 2025 Results, now scheduled for release on March 27, 2026.
This follows the Group's... ► Artikel lesen | |
| 29.01. | Magle Chemoswed Holding AB: Magle Group Announces Strategic Refocus to Strengthen Profitability and Operational Discipline | 285 | GlobeNewswire (Europe) | Magle Group today announces a strategic direction focused on strengthening profitability, operational discipline, and long-term value creation. The Group will prioritise its most established revenue-generating... ► Artikel lesen | |
| 21.01. | Magle Chemoswed Holding AB: Magle Group Announces Planned Transition in Chief Operating Officer Role | 236 | GlobeNewswire (Europe) | Magle Group today announces that Fredrik Andersson, Chief Operating Officer, will step down from his position during the coming months, as part of a planned leadership transition. This decision has... ► Artikel lesen | |
| 01.12.25 | Magle Chemoswed Holding AB: Magle Group Enters Strategic Distribution Agreement with Rifa Pharma for SmartPAN and SmartGEL in India. | 233 | GlobeNewswire (Europe) | Magle Group is pleased to announce that it has entered into an exclusive distribution agreement with Rifa Pharma for the Indian market, covering both SmartPAN® and SmartGEL®.
This partnership represents... ► Artikel lesen |
1 2 Weiter >>
25 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 48,050 | -0,81 % | Bayer: Ende der Korrektur noch nicht bestätigt | Nach den jüngsten Gewinnmitnahmen ist die Bayer-Aktie aus ihrer Konsolidierung nach oben ausgebrochen. Das verhaltene Handelsvolumen liefert bislang jedoch noch keine vollständige Bestätigung der Bewegung... ► Artikel lesen | |
| MERCK KGAA | 143,15 | +0,21 % | Laufende Fusionskontrollverfahren: Merck KGaA, Darmstadt; Erwerb sämtlicher ausgegebener Aktien an und alleiniger Kontrolle über Bio-Techne Corporation, Minneapolis, MN/USA | Datum der Anmeldung:23.07.2026Aktenzeichen:B3-84/26Unternehmen:Merck KGaA, Darmstadt; Erwerb sämtlicher ausgegebener Aktien an und alleiniger Kontrolle über Bio-Techne Corporation, Minneapolis, MN/USAProduktmärkte:Antikörper... ► Artikel lesen | |
| NOVO NORDISK | 40,900 | -7,36 % | Milliardenmärkte Adipositas, Onkologie und Neurologie im Fokus: Novo Nordisk, Vidac Pharma und AbbVie | Die Gesundheitsbranche der Zukunft wird von drei wesentlichen Megatrends angetrieben: Adipositas, Onkologie und Neurologie. Während der Markt für Krebsmedikamente auf fast 700 Mrd. USD zusteuert und... ► Artikel lesen | |
| APNIMED | 24,670 | -1,32 % | Apnimed, Inc.: Apnimed Announces Pricing of Upsized Initial Public Offering | CAMBRIDGE, Mass., July 30, 2026 /PRNewswire/ -- Apnimed, Inc. ("Apnimed"), a late stage clinical pharmaceutical company dedicated to the discovery, development... ► Artikel lesen | |
| ELI LILLY | 997,50 | +0,15 % | Keine Ende der Rallye in Sicht: Diese Biotechnologie-Aktie bietet für ihr Geld so viel wie kaum eine zweite! | © Foto: ZUMAPRESS.com | La Nacion - picture allianceTrotz eines enorm starken Wachstums und einer günstigen Unternehmensbewertung ist Halozyme noch immer ein Nischenwert. Das dürfte nicht mehr lange... ► Artikel lesen | |
| SANOFI | 75,00 | -0,32 % | BERNSTEIN RESEARCH stuft SANOFI auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Sanofi auf "Outperform" mit einem Kursziel von 107 Euro belassen. Die neue Konzernchefi unternehme weitere... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 46,430 | 0,00 % | Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI (hydrocortisone) Oral Solution | FDA submission seeks to bring KHINDIVI to larger pediatric patient population within the adrenal insufficiency marketNew formulation successfully demonstrated bioequivalence to ALKINDI SPRINKLESubmission... ► Artikel lesen | |
| LB PHARMACEUTICALS | 40,080 | 0,00 % | LB Pharmaceuticals Inc: LB Pharmaceuticals Announces $150 Million Private Placement | NEW YORK, July 29, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc ("LB Pharmaceuticals" or the "Company") (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact... ► Artikel lesen | |
| SCYNEXIS | 4,890 | +1,03 % | Brookline bestätigt Kursziel für Scynexis von 44,64 USD und sieht massives Aufwärtspotenzial | ||
| PFIZER | 21,770 | +0,30 % | Passives Einkommen: Darum schlägt dieser Crash-Prophet jetzt bei Dividendenwachstumswert Zoetis zu! | © Foto: wallstreetonline/KI - OpenAICrashprophet Michael Burry hat sich die Aktie des Spezialisten für Tiergesundheit und Dividendenwachstumswert Zoetis ins Depot gelegt. Dafür gibt es eine Menge guter... ► Artikel lesen | |
| KARDIGAN | 20,830 | +0,05 % | Kardigan, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | SOUTH SAN FRANCISCO, Calif. & PRINCETON, N.J.--(BUSINESS WIRE)--Kardigan, Inc. (Nasdaq: KARD) ("Kardigan"), a clinical-stage precision therapeutics company developing medicines that target the root... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 73,40 | +0,19 % | Motorola Solutions Foundation and Calculated Genius Honor Chicagoland Future Engineers With 2026 Bright Minds, Bold Futures Scholarship | NORTHAMPTON, MA / ACCESS Newswire / June 30, 2026 / Ten extraordinary Chicagoland high school seniors recently gathered at Motorola Solutions' global headquarters in Chicago, joined by family members... ► Artikel lesen | |
| DERMAPHARM | 41,000 | -1,91 % | dpa-AFX-Überblick: UNTERNEHMEN vom 17.07.2026 - 15.15 Uhr | ROUNDUP: SMA wird erneut optimistischer für 2026 - Aktie springt hoch NIESTETAL - Der Photovoltaik-Spezialist SMA Solar hat im zweiten Quartal nach vorläufigen Berechnungen besser abgeschnitten als... ► Artikel lesen | |
| SCHOTT PHARMA | 21,950 | -0,23 % | UBS stuft Schott Pharma auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für Schott Pharma von 25,90 auf 26,50 Euro angehoben und die Einstufung auf "Buy" belassen. Das neue Kursziel reflektiere den... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 3,695 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Reaffirms guidance to resubmit Anaphylm (dibutepinephrine) sublingual film NDA in Q3 2026Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union... ► Artikel lesen |
Das Unternehmen MAGLE CHEMOSWED HOLDING AB kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,028 Euro. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MAGLE CHEMOSWED HOLDING AB finden Sie auf Wallstreet Online.